
Professional Guidelines Included
Learn the Proximal femoral endoprosthesis: Adler Pantheon for reconstruction after radical excision of femoral metastasis and trochanteric reattachment using Kinamed SuperCables surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Proximal femoral endoprosthesis: Adler Pantheon for reconstruction after radical excision of femoral metastasis and trochanteric reattachment using Kinamed SuperCables surgical procedure.
Metastatic bone disease is becoming increasingly prevalent and more cases are presenting to orthopaedic surgeons. These patients may be referred by GPs or from emergency departments or oncologists with skeletal related events, such as severe pain, impending fracture or pathological fracture, metastatic spinal cord compression or hypercalcaemia.
Metastatic prostate cancer is the second most common presentation of metastatic bone disease to orthopaedic oncologists, after breast cancer. Prostate cancer frequently metastasises to bone and surgical options may include stabilisation of pathological fractures, arthroplasty, spinal decompression, resection and endoprosthetic reconstruction. Almost half the patients with prostate cancer who develop bone metastases develop skeletal related events within nine months of the development of skeletal disease.
In this case, a patient with carcinoma of the prostate was referred by their oncologist, having undergone whole-body staging for an increasing PSA using a Choline PET-CT, which identified an asymptomatic proximal femoral metastasis. After discussions between the patient, oncologist and surgeon, it was decided that there was an advantage to the patient of excision of this solitary prostate bone metastasis (oligometastasis = <3 metastatic lesions) for local control and improved oncological outcomes. The underlying principle regarding the term ‘oligometastatic’, coined in the 1990s, is that treatment still has curative intent, which sadly is rarely the case in patients with multiple metastases.
The patient underwent excision and reconstruction with a modular Adler Pantheon proximal femoral endoprosthesis with reattachment of the greater trochanter, to permit early weight-bearing and rapid return to function. The Adler Pantheon system was selected for this case because of the 3D printed bridging collar designed to achieve bone in- and on-growth to minimise the risk of aseptic loosening and trochanteric reattachment failure, the Agluna silver coating to minimise the risk of early prosthetic joint infection, and modularity to permit any possible segmental reconstruction of the proximal femur.

INDICATIONS
The indications for a proximal femoral endoprosthesis are to reconstruct segmental bone loss following excision of the proximal femur for bone tumours, failed trauma osteosynthesis or failed arthroplasty. Where the trochanter is not involved by the tumour and can be spared, it is thought to be advantageous to osteotomise the trochanter to preserve the attachments of the gluteus medius and the vastus lateralis, both to maintain function of these muscles and also to improve soft-tissue coverage of the prosthesis to minimise the risk of infection.
SYMPTOMS & EXAMINATION
Patients with proximal femoral metastasises usually present with pain, causing inability to bear weight, necessitating walking-aids. Patients with tumours with extra-osseous spread outside of the bone may have soft-tissue swelling apparent in the proximal thigh. Very large tumours may start to cause obstruction of venous return, causing generalised swelling of the whole limb and may start to involve neural structures such as the sciatic nerve causing neurological sequalae in very rare cases.
In this particular case, the patient was asymptomatic, as this tumour was detected both biochemically (PSA) and with whole-body imaging (PET-CT). Should the patient develop a pathological fracture, patients classically present with prodromal pain prior to a low energy fracture, out of keeping with the normal injury mechanism for a hip or femoral fracture.
IMAGING
All patients with suspected metastatic bone diseases, should have x-rays of the whole bone, so in this case an x-ray of the whole femur AP and lateral and MRI scan of the whole bone and if it involves the hip joint, to include the pelvis as well and they should have a staging CT chest, abdomen & pelvis. In this case, the patient already had a whole-body Choline PET-CT for distal staging, which confirmed that this was a solitary bone metastasis.
Other alternatives for distal skeletal staging, would include whole body bone scintigraphy or whole-body MRI. In addition, sometimes a CT scan is useful of the bony metastasis to assess for skeletal integrity or if one is planning a custom endoprosthesis.
If, a patient presents with a solitary metastasis a biopsy is usually indicated, as per the BOA (British Orthopaedic Association) guidelines 2015 (which are available in the guidelines section) to confirm the diagnosis and exclude the rare possibility of a primary bone tumour or of a different diagnosis. It is not uncommon for patients to have more than one diagnosis and in a recent investigation of our local data, it was found that in patients with a previous history of malignancy and a solitary bone lesion, 20% had a different diagnosis to their previous cancer.
Bone biopsy can be performed in theatre using a Jamshidi needle and image intensification or done using CT guidance by the radiology team.
Once the diagnosis is confirmed, then the patient’s case is normally discussed at a disease specific MDT, in this case the urology MDT and a discussion is had with the patient’s treating oncologist, who in this case referred the patient, prior to undergoing excision and reconstruction of the oligometastatic bone disease.
ALTERNATIVE OPERATIVE TREATMENT
Alternatives to surgical en-bloc resection and reconstruction may include intra-medullary nail stabilisation in a patient for palliative management of an impending or pathological fracture with polyostotic disease. In oligo-metastatic disease this would not excise the tumour, merely stabilise the bone. In non-oligometastatic disease, i.e. where the treatment intent is palliative, then cephalo-medullary nails would be reasonable but are associated with a high revision rate due to mechanical failure and disease progression.
NON-OPERATIVE MANAGEMENT
Non-operative management in general for metastatic bone disease, may include radiotherapy, hormone therapy, chemotherapy, immunotherapy and minimally invasive techniques may include cryotherapy or cementoplasty for pelvic disease.
In this case a Cyberknife, which is a form of targeted radiotherapy, was discussed but felt inappropriate because it is a weight-bearing bone, but this may be considered in other anatomical areas.
CONTRAINDICATIONS
Contraindications to surgery, include those patients whose prognosis is thought to be less than six months, in which case palliative radiotherapy maybe more appropriate, or in patients with multiple morbidities preventing anaesthesia and major surgery. Indications might include active infection or concurrent pulmonary embolus.

The patient is positioned right side down and left side up and appropriate anaesthetic (in this case combined spinal anaesthesia with general anaesthetic) with pressure aero protection and routine hip props with intravenous antibiotic prophylaxis administered one hour prior to skin incision (flucloxacillin and gentamicin as per local antimicrobial guidelines) and the urinary catheter and intravenous tranexamic acid.
The patient has isolation drapes and pre-operative skin cleansing, using alcoholic chlorhexidine twice with suction and electrocautery available.

IV antibiotics for 24 hours (floxacillin), low molecular weight heparin, thromboprophylaxis for 28 days post-operatively and thromboembolic stockings for 6 weeks post-operatively plus foot pumps whilst in bed as an inpatient.
No sutures to remove, wound check in 2 weeks.
Protected weight bearing with crutches for 6 weeks from tomorrow, under physiotherapy supervision.
Outpatient department, 6 weeks, repeat x-ray on arrival.
Neurovascular observations on high dependency and overnight.
Routine blood test next day and transfuse as appropriate.

Endoprosthetic reconstruction allows early weight bearing, shorter hospital stay, early return to daily living and commencement of post-operative adjuvant therapy. Aseptic loosening was the principle mode of failure of cemented lower-limb endoprosthetic replacements according to Unwin et al. (Unwin P, et al. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. JBJS(Br) 1996, 78(1):5-13. PMID: 8898118). The other causes of failure are local recurrence, infection, dislocation and peri-prosthetic fracture. Aseptic loosening of the first generation of proximal femoral endoprostheses was reduced by the addition of hydroxyapatite (HA) collars at the bone-prosthesis interface in the 1990s. It was first reported in animal models that HA coated collars generated new bone that enhanced fixation and encouraged the osseo-integration, offering an alternative to the use of intramedullary cemented stems in patients with only a short segment of bone remaining (Stevenson JD, Wigley C, Burton H, Ghezelayagh S, Morris G, Evans S, Parry M, Jeys L. Minimising aseptic loosening in extreme bone resections: custom-made tumour endoprostheses with short medullary stems and extra-cortical plates. Bone Joint J. 2017 Dec;99-B(12):1689-1695. PMID: 29212694).
Porous metal coatings have become routine in primary and revision hip arthroplasty. The addition of a 3D-printed porous collar to endoprosthetic replacement with endosteal integration may further reduce the incidence of aseptic loosening. Trials are underway within the UK to investigate this further at the Royal Orthopaedic Hospital, Birmingham and RNOH, Stanmore (https://clinicaltrials.gov/ct2/show/NCT03905174?term=MING&draw=2&rank=2).
Endoprosthetic reconstruction allows early weight bearing, shorter hospital stay, early return to daily living and commencement of post-operative adjuvant therapy. Aseptic loosening was the principle mode of failure of cemented lower-limb endoprosthetic replacements according to Unwin et al. (Unwin P, et al. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. JBJS(Br) 1996, 78(1):5-13. PMID: 8898118). The other causes of failure are local recurrence, infection, dislocation and peri-prosthetic fracture. Aseptic loosening of the first generation of proximal femoral endoprostheses was reduced by the addition of hydroxyapatite (HA) collars at the bone-prosthesis interface in the 1990s. It was first reported in animal models that HA coated collars generated new bone that enhanced fixation and encouraged the osseo-integration, offering an alternative to the use of intramedullary cemented stems in patients with only a short segment of bone remaining (Stevenson JD, Wigley C, Burton H, Ghezelayagh S, Morris G, Evans S, Parry M, Jeys L. Minimising aseptic loosening in extreme bone resections: custom-made tumour endoprostheses with short medullary stems and extra-cortical plates. Bone Joint J. 2017 Dec;99-B(12):1689-1695. PMID: 29212694).
Porous metal coatings have become routine in primary and revision hip arthroplasty. The addition of a 3D-printed porous collar to endoprosthetic replacement with endosteal integration may further reduce the incidence of aseptic loosening. Trials are underway within the UK to investigate this further at the Royal Orthopaedic Hospital, Birmingham and RNOH, Stanmore (https://clinicaltrials.gov/ct2/show/NCT03905174?term=MING&draw=2&rank=2).
Reference
- orthoracle.com


















































































